<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report 2 patients showing invasion of <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> into the central nerve system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) </plain></SENT>
<SENT sid="1" pm="."><plain>Patient 1, an 81-year-old woman, underwent surgery for sphenoidal <z:hpo ids='HP_0000246'>sinusitis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>She developed <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> with unconsciousness on 12th postoperative day </plain></SENT>
<SENT sid="3" pm="."><plain>CSF examination demonstrated pleocytosis with increased protein and aspergillus antigen </plain></SENT>
<SENT sid="4" pm="."><plain>She was diagnosed as having invasion of <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> into the <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>, and was treated with <z:chebi fb="0" ids="10023">voriconazole</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Her clinical manifestations and CSF findings markedly improved </plain></SENT>
<SENT sid="6" pm="."><plain>However, the effects of <z:chebi fb="0" ids="10023">voriconazole</z:chebi> gradually attenuated and she demonstrated recurrence of the <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>After 2 months, she died of <z:e sem="disease" ids="C0343856" disease_type="Disease or Syndrome" abbrv="">systemic aspergillosis</z:e> and <z:hpo ids='HP_0100806'>sepsis</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Autopsy studies </plain></SENT>
<SENT sid="9" pm="."><plain>Severe atherosclerotic changes with calcification were demonstrated in the bilateral carotid and basilar arteries, and many aspergillus were clustered in the vessel walls </plain></SENT>
<SENT sid="10" pm="."><plain>Granulomatous inflammatory lesions with aspergillus were also demonstrated in the area surrounding the chiasm </plain></SENT>
<SENT sid="11" pm="."><plain>There were no massive <z:mpath ids='MPATH_124'>infarcts</z:mpath> or <z:mp ids='MP_0001914'>bleeding</z:mp> in the brain, but multiple small <z:mpath ids='MPATH_124'>infarcts</z:mpath> were present </plain></SENT>
<SENT sid="12" pm="."><plain>Patinet 2, a 64-year-old man, showing bilateral <z:hpo ids='HP_0000572'>visual loss</z:hpo>, was receiving treatment with <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> under a diagnosis of <z:hpo ids='HP_0100653'>optic neuritis</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain>Two weeks later, he developed <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>CSF examination showed pleocytosis with increased protein and aspergillus antigen </plain></SENT>
<SENT sid="15" pm="."><plain>He was diagnosed as having invasive <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> from the sphenoidal <z:hpo ids='HP_0000246'>sinusitis</z:hpo> into the <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> </plain></SENT>
<SENT sid="16" pm="."><plain>He was treated with <z:chebi fb="0" ids="10023">voriconazole</z:chebi>, and unconsciousness and CSF findings improved transiently </plain></SENT>
<SENT sid="17" pm="."><plain>However, he developed a recurrence of the <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> and <z:hpo ids='HP_0002090'>pneumonia</z:hpo> and finally died 6 months later </plain></SENT>
<SENT sid="18" pm="."><plain>Treatment by <z:chebi fb="0" ids="10023">voriconazole</z:chebi> was definitely effective in both patients, but both patients died of recurrent <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e>, possibly due to resistance for <z:chebi fb="0" ids="10023">voriconazole</z:chebi>, or developing multicellular filamentous biofilms </plain></SENT>
<SENT sid="19" pm="."><plain><z:chebi fb="0" ids="10023">Voriconazole</z:chebi> is recommended as the first choice of antifungal agents for <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> </plain></SENT>
<SENT sid="20" pm="."><plain><z:e sem="disease" ids="C0851807" disease_type="Disease or Syndrome" abbrv="">Aspergillus infection</z:e> is strongly invasive into arterial vessels </plain></SENT>
<SENT sid="21" pm="."><plain>It is important to consider the possible occurrence of cerebrovascular disease when treating invasion of <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> into the <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> </plain></SENT>
</text></document>